Keynote Speakers

  • Co-founder of The Align Foundation & CEO of Pioneer Labs

    How do we make the next PDB? Introducing Align's Data Platform

    Recent machine learning successes like Alphafold II highlight the utility of large, high-fidelity datasets in life science. The Align Foundation develops experimental platforms and coordinates large-scale data generation across academic and automation partners. Its end-to-end process includes community roadmapping, protocol standardization, reproducible data collection, and benchmarking predictive models. Align’s mission is to create a world where biological data is more reproducible, scalable, and shareable.

  • Associate Professor of Cancer Data Research and Biomedical Engineering at Columbia University

    Machine Learning for Decoding Tumor Microenvironment Dynamics

    The tumor microenvironment (TME) profoundly shapes tumor progression and response to therapies. My lab develops rigorous machine learning methods to unravel complex tumor-immune interactions using single-cell and spatial multi-omics data from patient specimens. In this talk, I will discuss computational frameworks designed to decode spatial and temporal dynamics of the TME, integrating spatial transcriptomics, histology imaging, and single-cell sequencing. I will present deep generative models for representation learning and multi-modal integration, enabling us to identify key metabolic and immunosuppressive hubs associated with aggressive subtypes of breast cancer. I will also showcase probabilistic and attention-based models that pinpoint crucial cell-cell interactions and T cell subsets critical for immunotherapy response in leukemia. Moreover, I will introduce causal discovery approaches and Bayesian tools to disentangle genetic and environmental drivers of phenotypic plasticity linked to immunotherapy resistance in melanoma. Finally, our computational tools reconstruct cell-state trajectories, uncovering dysregulated gene regulatory networks involved in leukemia initiation. Altogether, our machine learning toolkit has the potential to advance precision cancer therapies through decoding the principles of TME dynamics.

  • Senior VP and Head of Computation at Genentech Research and Early Development

    Talk Title: TBD

  • Professor at Icahn School of Medicine at Mount Sinai

    Deciphering Interindividual Variability in Brain Transcriptomes Through Single-Cell Analysis

    This talk will present recent advances from large-scale single-cell and spatial transcriptomic efforts across neurodegenerative and neuropsychiatric diseases, with a focus on population-scale studies integrating diverse ancestries. I will highlight how integrating genetic data with single-nucleus RNA-seq enables identification of cell-type-specific mechanisms and how these findings inform disease heritability and cross-disorder biology.

Our sponsors

DIAMOND

SILVER